Drug intelligence / Profile preview

AS-8351

Development stage
Preclinical
Lead developer
Texas A&M University
Modality
Small Molecules
Administration
Oral
01

Overview

AS-8351 is a small molecule epigenetic modulator that acts as a potent and selective inhibitor of the histone lysine demethylase KDM5B (also known as JARID1B). KDM5B is a member of the JARID1 family of demethylases that specifically targets tri- and di-methylated lysine 4 on histone H3 (H3K4me3/2), a modification typically associated with active transcription. By inhibiting KDM5B, AS-8351 promotes the maintenance of H3K4 methylation levels, thereby influencing gene expression patterns involved in cell differentiation and proliferation. Research has demonstrated its potential in oncology, particularly in pediatric brain tumors like glioblastoma and medulloblastoma, where it has shown efficacy in suppressing tumor organoid growth both alone and in combination with radiation therapy. It is primarily utilized as a chemical probe in preclinical research.

02

Targets

KDM5B (Lysine-specific demethylase 5B)

Beyond the preview

Go deeper on AS-8351.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AS-8351.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call